Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect.
Urien S, Doz F, Giraud C, Rey E, Gentet JC, Chastagner P, Vassal G, Corradini N, Auvrignon A, Leblond P, Rubie H, Treluyer JM. Urien S, et al. Among authors: treluyer jm. Cancer Chemother Pharmacol. 2011 Mar;67(3):597-603. doi: 10.1007/s00280-010-1357-2. Epub 2010 May 20. Cancer Chemother Pharmacol. 2011. PMID: 20490798 Clinical Trial.
Tocolytic effects of intravenous nitroglycerin.
de Spirlet M, Treluyer JM, Chevret S, Rey E, Tournaire M, Cabrol D, Pons G. de Spirlet M, et al. Among authors: treluyer jm. Fundam Clin Pharmacol. 2004 Apr;18(2):207-13. doi: 10.1111/j.1472-8206.2003.00231.x. Fundam Clin Pharmacol. 2004. PMID: 15066136 Clinical Trial.
Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women.
Chappuy H, Tréluyer JM, Jullien V, Dimet J, Rey E, Fouché M, Firtion G, Pons G, Mandelbrot L. Chappuy H, et al. Among authors: treluyer jm. Antimicrob Agents Chemother. 2004 Nov;48(11):4332-6. doi: 10.1128/AAC.48.11.4332-4336.2004. Antimicrob Agents Chemother. 2004. PMID: 15504861 Free PMC article. Clinical Trial.
Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.
Jullien V, Tréluyer JM, Rey E, Jaffray P, Krivine A, Moachon L, Lillo-Le Louet A, Lescoat A, Dupin N, Salmon D, Pons G, Urien S. Jullien V, et al. Among authors: treluyer jm. Antimicrob Agents Chemother. 2005 Aug;49(8):3361-6. doi: 10.1128/AAC.49.8.3361-3366.2005. Antimicrob Agents Chemother. 2005. PMID: 16048948 Free PMC article.
400 results